2D chemometrics analyses of tetrahydroquinoline and ethylenediamine derivatives with antimalarial activity

Medicinal Chemistry

Volumn 8, Issue 2, 2012, Pages 252-265

  Freitas, Humberto Fonseca De ^a   Castilho, Marcelo Santos ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

Antimalarial activity; Chemometric analysis; Classical 2D QSAR; Ethylenediamine; Hologram QSAR; Tetrahydroquinoline.

Indexed keywords

ETHYLENEDIAMINE DERIVATIVE; QUINOLINE DERIVATIVE; TETRAHYDROQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; CHEMOMETRIC ANALYSIS; DRUG DESIGN; DRUG POTENCY; DRUG STRUCTURE; EXPLORATORY RESEARCH; HYDROPHILICITY; HYDROPHOBICITY; NONBIOLOGICAL MODEL; PHYSICAL CHEMISTRY; PLASMODIUM FALCIPARUM; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 84861957338     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/157340612800493575     Document Type: Article

References (61)

1. Sahu, N. K.; Sahu, S.; Kohli, D. V. Novel molecular targets for antimalarial drug development. Chem. Biol. Drug Des. 2008, 71(4), 287-297 (Pubitemid 351347791)
2. WHO. World malaria report 2008; World Health Organization: Geneva, 2008
3. Snow, R. W.; Guerra, C. A.; Noor, A. M.; Myint, H. Y.; Hay, S. I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature, 2005, 434(7030), 214-217 (Pubitemid 40388051)
4. Hyde, J. E.Drug-resistant malaria -an insight. FEBS, 2007, 274(18), 4688-4698
5. Greenwood, B.; Mutabingwa, T. Malaria in 2002. Nature, 2002, 415(6872), 670-672 (Pubitemid 34136399)
6. Singh, V.; Tyagi, L.; Singhal, M.; Sharma, C.; Kori, M. A new generation of 7-Chloro-4-Aminoquinoline antimalarials. Syst. Rev. Pharm. 2010, 1(2), 182-189
7. Clough, B.; Wilson, R. J. M. In Antimalarial Chemotherapy: Mechanisms of Action, Resistance, and New Directions in Drug Discovery; Rosenthal, P. J., Ed.; Humana Press Inc.: Totowa, 2001, pp. 265-286
8. Loyevsky, M.; Gordeuk, V. R. In Antimalarial Chemotherapy: Mechanisms of Action, Resistance, and New Directions in Drug Discovery; Rosenthal, P. J., Ed.; Humana Press Inc: Totowa, 2001, pp. 307-324
9. Chakrabarti, D.; Azam, T.; DelVecchio, C.; Qiu, L.; Park, Y. I.; Allen, C. M. Protein prenyl transferase activities of Plasmodiumfalciparum. Mol. Biochem. Parasitol. 1998, 94(2), 175-184 (Pubitemid 28377284)
10. Gelb, M. H.; Van Voorhis, W. C.; Buckner, F. S.; Yokoyama, K.; Eastman, R.; Carpenter, E. P.; Panethymitaki, C.; Brown, K. A.; Smith, D. F. Protein farnesyl and N-myristoyl transferases: piggyback medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics. Mol. Biochem. Parasitol. 2003, 126(2), 155-163 (Pubitemid 36255614)
11. Nallan, L.; Bauer, K. D.; Bendale, P.; Rivas, K.; Yokoyama, K.; Horney, C. P.; Pendyala, P. R.; Floyd, D.; Lombardo, L. J.; Williams, D. K.; Hamilton, A.; Sebti, S.; Windsor, W. T.; Weber, P. C.; Buckner, F. S.; Chakrabarti, D.; Gelb, M. H.; Van Voorhis, W. C.Protein farnesyltransferase inhibitors exhibit potent antimalarial activity. J. Med. Chem. 2005, 48(11), 3704-3713 (Pubitemid 40776846)
12. Nwaka, S.; Riopel, L.; Ubben, D.; Craft, J. C. Medicines for Malaria Venture new developments in antimalarials. Travel. Med. Infect. Dis. 2004, 2(3-4), 161-170 (Pubitemid 39236770)
13. Eastman, R. T.; Buckner, F. S.; Yokoyama, K.; Gelb, M. H.; Van Voorhis, W. C. Thematic review series: lipid posttranslational modifications. Fighting parasitic disease by blocking protein farnesylation. J. Lipid. Res. 2006, 47(2), 233-240
14. Krungkrai, S. R.; Krungkrai, J. Malaria parasite carbonic anhydrase: inhibition of aromatic/heterocyclic sulfonamides and its therapeutic potential. Asian Pac. J. Trop. Biomed. 2011, 1(3), 233-242
15. Crowther, G. J.; Napuli, A. J.; Gilligan, J. H.; Gagaring, K.; Borboa, R.; Francek, C.; Chen, Z.; Dagostino, E. F.; Stockmyer, J. B.; Wang, Y.; Rodenbough, P. P.; Castaneda, L. J.; Leibly, D. J.; Bhandari, J.; Gelb, M. H.; Brinker, A.; Engels, I. H.; Taylor, J.; Chatterjee, A. K.; Fantauzzi, P.; Glynne, R. J.; Van Voorhis, W. C.; Kuhen, K. L. Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds. Mol. Biochem. Parasitol. 2011, 175(1), 21-29
16. Aparicio, I. M.; Marin-Menendez, A.; Bell, A.; Engel, P. C. Susceptibility of Plasmodium falciparum to glutamate dehydrogenase inhibitors-a possible new antimalarial target. Mol. Biochem. Parasitol. 2010, 172(2), 152-155
17. Aurrecoechea, C.; Brestelli, J.; Brunk, B. P.; Dommer, J.; Fischer, S.; Gajria, B.; Gao, X.; Gingle, A.; Grant, G.; Harb, O. S.; Heiges, M.; Innamorato, F.; Iodice, J.; Kissinger, J. C.; Kraemer, E.; Li, W.; Miller, J. A.; Nayak, V.; Pennington, C.; Pinney, D. F.; Roos, D. S.; Ross, C.; Stoeckert, C. J., Jr.; Treatman, C.; Wang, H. PlasmoDB: a functional genomic database for malaria parasites. Nucleic. Acids Res. 2009, 37, 539-543
18. Bendale, P.; Olepu, S.; Suryadevara, P. K.; Bulbule, V.; Rivas, K.; Nallan, L.; Smart, B.; Yokoyama, K.; Ankala, S.; Pendyala, P. R.; Floyd, D.; Lombardo, L. J.; Williams, D. K.; Buckner, F. S.; Chakrabarti, D.; Verlinde, C. L.; Van Voorhis, W. C.; Gelb, M. H. Second generation tetrahydroquinoline-based protein farnesyltransferase inhibitors as antimalarials. J. Med. Chem. 2007, 50(19), 4585-4605 (Pubitemid 47463234)
19. Carrico, D.; Ohkanda, J.; Kendrick, H.; Yokoyama, K.; Blaskovich, M. A.; Bucher, C. J.; Buckner, F. S.; Van Voorhis, W. C.; Chakrabarti, D.; Croft, S. L.; Gelb, M. H.; Sebti, S. M.; Hamilton, A. D. In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability. Bioorg. Med. Chem. 2004, 12(24), 6517-6526 (Pubitemid 39535174)
20. Eastman, R. T.; White, J.; Hucke, O.; Bauer, K.; Yokoyama, K.; Nallan, L.; Chakrabarti, D.; Verlinde, C. L.; Gelb, M. H.; Rathod, P. K.; Van Voorhis, W. C. Resistance to a protein farnesyltransferase inhibitor Plasmodium falciparum. J. Biol. Chem. 2005, 280(14), 13554-13559 (Pubitemid 40517247)
21. Eastman, R. T.; White, J.; Hucke, O.; Yokoyama, K.; Verlinde, C. L.; Hast, M. A.; Beese, L. S.; Gelb, M. H.; Rathod, P. K.; Van Voorhis, W. C. Resistance mutations at the lipid substrate binding site of Plasmodium falciparum protein farnesyltransferase. Mol. Biochem. Parasitol. 2007, 152(1), 66-71 (Pubitemid 46107701)
22. Fletcher, S.; Cummings, C. G.; Rivas, K.; Katt, W. P.; Horney, C.; Buckner, F. S.; Chakrabarti, D.; Sebti, S. M.; Gelb, M. H.; Van Voorhis, W. C.; Hamilton, A. D. Potent, Plasmodium-selective farnesyltransferase inhibitors that arrest the growth of malaria parasites: structure-activity relationships of ethylenediamineanalogue scaffolds and homology model validation. J. Med. Chem. 2008, 51(17), 5176-5197
23. Glenn, M. P.; Chang, S. Y.; Horney, C.; Rivas, K.; Yokoyama, K.; Pusateri, E. E.; Fletcher, S.; Cummings, C. G.; Buckner, F. S.; Pendyala, P. R.; Chakrabarti, D.; Sebti, S. M.; Gelb, M.; Van Voorhis, W. C.; Hamilton, A. D. Structurally simple, potent, Plasmodium selective farnesyltransferase inhibitors that arrest the growth of malaria parasites. J. Med. Chem. 2006, 49(19), 5710-5727 (Pubitemid 44423709)
24. Hast, M. A.; Fletcher, S.; Cummings, C. G.; Pusateri, E. E.; Blaskovich, M. A.; Rivas, K.; Gelb, M. H.; Van Voorhis, W. C.; Sebti, S. M.; Hamilton, A. D.; Beese, L. S. Structural basis for binding and selectivity of antimalarial and anticancer ethylenediamine inhibitors to protein farnesyltransferase. Chem. Biol. 2009, 16(2), 181-192
25. Ohkanda, J.; Lockman, J. W.; Yokoyama, K.; Gelb, M. H.; Croft, S. L.; Kendrick, H.; Harrell, M. I.; Feagin, J. E.; Blaskovich, M. A.; Sebti, S. M.; Hamilton, A. D. Peptidomimetic inhibitors of protein farnesyltransferase show potent antimalarial activity. Bioorg. Med. Chem. Lett. 2001, 11(6), 761-764 (Pubitemid 32230674)
26. Olepu, S.; Suryadevara, P. K.; Rivas, K.; Yokoyama, K.; Verlinde, C. L.; Chakrabarti, D.; Van Voorhis, W. C.; Gelb, M. H. 2-Oxotetrahydro-1,8- naphthyridines as selective inhibitors of malarial protein farnesyltransferase and as anti-malarials. Bioorg. Med. Chem. Lett. 2008, 18(2), 494-497
27. Van Voorhis, W. C.; Rivas, K. L.; Bendale, P.; Nallan, L.; Horney, C.; Barrett, L. K.; Bauer, K. D.; Smart, B. P.; Ankala, S.; Hucke, O.; Verlinde, C. L.; Chakrabarti, D.; Strickland, C.; Yokoyama, K.; Buckner, F. S.; Hamilton, A. D.; Williams, D. K.; Lombardo, L. J.; Floyd, D.; Gelb, M. H. Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase. Antimicrob. Agents Chemother. 2007, 51(10), 3659-3671 (Pubitemid 47519357)
28. Xie, A.; Sivaprakasam, P.; Doerksen, R. J. 3D-QSAR analysis of antimalarial farnesyltransferase inhibitors based on a 2,5-diaminobenzophenone scaffold. Bioorg. Med. Chem. 2006, 14(21), 7311-7323 (Pubitemid 44403103)
29. Sahu, N. K.; Sharma, M. C.; Mourya, V.; Kohli, D. V. QSAR studies of some side chain modified 7-chloro-4-aminoquinolines as antimalarial agents. Arabian J. Chem. 2010, in press
30. Bringmann, G.; Bischof, S. K.; Muller, S.; Gulder, T.; Winter, C.; Stich, A.; Moll, H.; Kaiser, M.; Brun, R.; Dreher, J.; Baumann, K. QSAR guided synthesis of simplified antiplasmodial analogs of naphthylisoquinoline alkaloids. Eur. J. Med. Chem. 2010, 45(11), 5370-5383
31. Ojha, P. K.; Roy, K. Chemometric modeling, docking and in silico design of triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors as antimalarials. Eur. J. Med. Chem. 2010, 45(10), 4645-4656
32. Gramatica, P.; Corradi, M.; Consonni, V. Modelling and prediction of soil sorption coefficients of non-ionic organic pesticides by molecular descriptors. Chemosphere, 2000, 41(5), 763-777 (Pubitemid 30266108)
33. Todeschini, R.; Consonni, V.; Mauri, A.; Pavan, M. In Data Handling in Science and Technology; Leardi, R., Ed.; Elsevier, 2003; 23, pp. 141-167
34. Todeschini, R.; Consonni, V.; Mauri, A.; Pavan, M. Detecting bad regression models: multicriteria fitness functions in regression analysis. Anal. Chim. Acta, 2004, 515(1), 199-208 (Pubitemid 38798221)
35. Castilho, M. S.; Postigo, M. P.; de Paula, C. B.; Montanari, C. A.; Oliva, G.; Andricopulo, A. D. Two-and three-dimensional quantitative structure-activity relationships for a series of purine nucleoside phosphorylase inhibitors. Bioorg. Med. Chem. 2006, 14(2), 516-527 (Pubitemid 41767612)
36. Schuurmann, G.; Ebert, R. U.; Chen, J.; Wang, B.; Kuhne, R. External validation and prediction employing the predictive squared correlation coefficient test set activity mean vs training set activity mean. J. Chem. Infor. Model. 2008, 48(11), 2140-2145
37. Ojha, P. K.; Mitra, I.; Das, R. N.; Roy, K. Further exploring rm2 metrics for validation of QSPR models. Chemometr. Intell. Lab. 2011, 107(1), 194-205
38. Pratim Roy, P.; Paul, S.; Mitra, I.; Roy, K. On two novel parameters for validation of predictive QSAR models. Molecules 2009, 14(5), 1660-1701
39. Roy, P. P.; Roy, K. On some aspects of variable selection for partial least squares regression models. QSAR Combinatorial Sci. 2008, 27(3), 302-313
40. Puntambekar, D. S.; Giridhar, R.; Yadav, M. R. Insights into the structural requirements of farnesyltransferase inhibitors as potential anti-tumor agents based on 3D-QSAR CoMFA and CoMSIA models. Eur. J. Med. Chem. 2008, 43(1), 142-154
41. Freitas, H. F.; Paz, O. S.; Castilho, M. S. Qsar 3d Studies of a Series of Human Butyrylcholinesterase Inhibitors. Quim. Nova, 2009, 32(8), 2114-2153
42. Castilho, M. S.; Postigo, M. P.; Pereira, H. M.; Oliva, G.; Andricopulo, A. D. Structural basis for selective inhibition of purine nucleoside phosphorylase from Schistosoma mansoni: Kinetic and structural studies. Bioorg. Med. Chem. 2010, 18(4), 1421-1427
43. Castilho, M. S.; C. Guido, R. V.; Andricopulo, A. D. Classical and Hologram QSAR Studies on a Series of Tacrine Derivatives as Butyrylcholinesterase Inhibitors. Lett. Drug Des. Disc. 2007, 4, 106-113 (Pubitemid 46121456)
44. Yuan, H.; Wang, Y.; Cheng, Y. Local and global quantitative structure-activity relationship modeling and prediction for the baseline toxicity. J. Chem. Inf. Model. 2007, 47(1), 159-169
45. Peltason, L.; Hu, Y.; Bajorath, J.From structure-activity to structure-selectivity relationships: quantitative assessment, selectivity cliffs, and key compounds. Chem. Med. Chem. 2009, 4(11), 1864-1873
46. Sisay, M. T.; Peltason, L.; Bajorath, J. Structural interpretation of activity cliffs revealed by systematic analysis of structure-activity relationships in analog series. J. Chem. Inf. Model. 2009, 49(10), 2179-2189
47. Todeschini, R.; Consonni, V.; Mannhold, R.; Kubinyi, H.; Timmerman, H., Handbook of Molecular Descriptors. Wiley-VCH, 2000
48. Guido, R.; Castilho, M.; Mota, S.; Oliva, G.; Andricopulo, A. Classical and hologram QSAR studies on a series of inhibitors of trypanosomatid glyceraldehyde-3-Phosphate dehydrogenase. QSAR Comb. Sci. 2008, 27(6), 768-781
49. Mota, S. G. R.; Barros, T. F.; Castilho, M. S. 2D QSAR studies on a series of bifonazole derivatives with antifungal activity. J. Brazil. Chem. Soc. 2009, 20(3), 451-459
50. Estrada, E.; Ramírez, A. Edge Adjacency relationships and molecular topographic descriptors. definition and QSAR applications. J. Chem. Inf. Comput. Sci. 1996, 36(4), 837-843
51. Viswanadhan, V. N.; Ghose, A. K.; Revankar, G. R.; Robins, R. K. Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics. J. Chem. Inf. Comput. Sci. 1989, 29(3), 163-172
52. Diudea, M. V.; Topan, M.; Graovac, A. Molecular Topology. 17. Layer Matrixes of Walk Degrees. J. Chem. Inf. Comput. Sci. 1994, 34(5), 1072-1078
53. Benigni, R.; Passerini, L.; Pino, A.; Giuliani, A. The information content of the eigenvalues from modified adjacency matrices: Large scale and small scale correlations. Quant. Struct.-Act. Rel. 1999, 18(5), 449-455
54. Burden, F. R. A chemically intuitive molecular index based on the eigenvalues of a modified adjacency matrix. Quant. Struct.-Act. Rel. 1997, 16 (4), 309-314 (Pubitemid 27401784)
55. Rucker, C.; Rucker, G. Mathematical relation between extended connectivity and eigenvector coefficients. J. Chem. Inf. Comput. Sci. 1994, 34(3), 534-538
56. Rucker, G.; Rucker, C. Counts of all walks as atomic and molecular descriptors. J. Chem. Inf. Comput. Sci. 1993, 33(5), 683-695
57. Rucker, G.; Rucker, C. Walk counts, labyrinthicity, and complexity of acyclic and cyclic graphs and molecules. J. Chem. Inf. Comput. Sci. 2000, 40(1), 99-106
58. Randi, M.; Wilkins, C. L. A Procedure for characterization of the rings of a molecule. J. Chem. Inf. Comput. Sci. 1980, 20(1), 36-46
59. Ghose, A. K.; Crippen, G. M. Atomic physicochemical parameters for three-dimensional structure-directed quantitative structureactivity relationships I. partition coefficients as a measure of hydrophobicity. J. Comput. Chem. 1986. 7, 565-577
60. Ghose, A. K.; Pritchett, A.; Crippen, G. M. Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships III: Modeling hydrophobic interactions. J. Comput. Chem. 1988. 9, 80-90
61. Pearlman, R. S.; Smith, K. M. Metric validation and the receptorrelevant subspace concept. J. Chem. Inform. Comput. Sci. 1999, 39(1), 28-35. (Pubitemid 129676554)